211 related articles for article (PubMed ID: 36436191)
1. Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.
Massironi S; Rossi RE; Laffusa A; Eller-Vainicher C; Cavalcoli F; Zilli A; Ciafardini C; Sciola V; Invernizzi P; Peracchi M
J Endocrinol Invest; 2023 May; 46(5):957-965. PubMed ID: 36436191
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study.
Massironi S; Cavalcoli F; Elvevi A; Quatrini M; Invernizzi P
Endocrine; 2022 Mar; 75(3):942-948. PubMed ID: 34716542
[TBL] [Abstract][Full Text] [Related]
3. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
5. Zollinger-Ellison syndrome due to primary gastrinoma of the extrahepatic biliary tree: three case reports and review of literature.
Price TN; Thompson GB; Lewis JT; Lloyd RV; Young WF
Endocr Pract; 2009; 15(7):737-49. PubMed ID: 19491075
[TBL] [Abstract][Full Text] [Related]
6. The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?
Guarnotta V; Martini C; Davì MV; Pizza G; Colao A; Faggiano A;
Endocrine; 2018 Apr; 60(1):15-27. PubMed ID: 29019150
[TBL] [Abstract][Full Text] [Related]
7. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
[TBL] [Abstract][Full Text] [Related]
8. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
Mignon M
Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
11. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
12. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
Ann Surg; 2001 Oct; 234(4):495-505; discussion 505-6. PubMed ID: 11573043
[TBL] [Abstract][Full Text] [Related]
13. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
Gibril F; Schumann M; Pace A; Jensen RT
Medicine (Baltimore); 2004 Jan; 83(1):43-83. PubMed ID: 14747767
[TBL] [Abstract][Full Text] [Related]
15. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.
Ruszniewski P; Podevin P; Cadiot G; Marmuse JP; Mignon M; Vissuzaine C; Bonfils S; Lehy T
Pancreas; 1993 May; 8(3):295-304. PubMed ID: 8097874
[TBL] [Abstract][Full Text] [Related]
16. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
17. Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1).
Norton JA; Jensen RT
Surg Oncol; 2003 Aug; 12(2):145-51. PubMed ID: 12946485
[TBL] [Abstract][Full Text] [Related]
18. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
[TBL] [Abstract][Full Text] [Related]
19. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.
Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
Ann Surg; 2003 May; 237(5):650-7; discussion 657-9. PubMed ID: 12724631
[TBL] [Abstract][Full Text] [Related]
20. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome.
Norton JA; Fraker DL; Alexander HR; Jensen RT
Ann Surg; 2012 Sep; 256(3):509-17. PubMed ID: 22868363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
